文献速递颈动脉与弓上血管

自发性颈动脉夹层的经股动脉支架与经颈动脉血运重建:多机构研究

Safety and Efficacy of Spontaneous Carotid Artery Dissection Management with Transfemoral Carotid Artery Stenting and Transcarotid Artery Revascularization: A Multi-Institutional Study.
PubMed 文献 · Ann Vasc Surg · 2025-05-26

基于VQI数据库2016-2024年458例自发性颈动脉夹层患者的回顾性分析,比较经股动脉颈动脉支架(TFCAS,67.9%)与经颈动脉血运重建(TCAR,32.1%)的结局。总体30天死亡率2.4%、卒中2%、MACE 4.4%;TCAR的30天死亡率、卒中、MACE、技术失败及入路并发症数值均低于TFCAS,但差异无统计学意义(P>0.05)。

要点

  • 458例自发性颈动脉夹层患者中TFCAS占67.9%、TCAR占32.1%。
  • 总体30天死亡率2.4%、卒中2%、MACE 4.4%、入路并发症4%。
  • TCAR的30天死亡率、卒中、MACE数值低于TFCAS,但差异无统计学意义。

核心结论

  • 两种术式均显示可接受的卒中和死亡发生率,TCAR虽无统计学显著性,但数值上技术成功率和围术期结局更优。

研究设计与样本

  • 基于Vascular Quality Initiative数据库(2016-2024)的回顾性分析,纳入458例因自发性颈动脉夹层接受TFCAS或TCAR的患者,采用多因素logistic回归校正混杂因素。

主要发现

  • TCAR组患者年龄更大、合并症更多,TFCAS组症状性比例更高。
  • 两组双支架使用率相似(TCAR 20.3% vs TFCAS 26.3%,P=0.08)。
  • 全部颈动脉支架病例中,30天死亡率2.4%,院内死亡1.7%,卒中2%,心肌梗死0.7%。
  • 卒中/死亡3.7%,MACE 4.4%,入路并发症4%,技术失败0.2%。
  • TCAR较TFCAS的30天死亡率(1.2% vs 2.9%)、卒中(0.7% vs 2.7%)、MACE(2% vs 5.5%)、技术失败(0% vs 0.3%)、入路并发症(2% vs 4.8%)数值更低,但差异均无统计学意义(P>0.05)。

临床怎么用

  • 对于自发性颈动脉夹层,TFCAS和TCAR均可作为治疗选择,两者卒中与死亡发生率可接受。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid artery dissection (CD) could lead to stroke, particularly in younger patients. Most studies assessing the safety of carotid artery stenting have excluded patients with dissections. We aim to fill that knowledge gap by evaluating and comparing the outcomes of transfemoral carotid artery stenting (TFCAS) and transcarotid artery revascularization (TCAR) in the management of spontaneous CD using a national database. METHODS: This is a retrospective analysis of all patients who underwent either TFCAS or TCAR for spontaneous carotid dissection in the Vascular Quality Initiative database (2016-2024). The primary outcomes were 30-day mortality and in-hospital major adverse cardiovascular event (MACE), including stroke, death, and myocardial infarction. Multivariate logistic regression models were employed to adjust for potential confounders. RESULTS: There were 458 patients treated with TFCAS (310; 67.9%) or TCAR (148; 32.1%) for CD. TCAR patients were older with more medical comorbidities, while TFCAS patients were more likely to be symptomatic. Two-stent usage was similar between the two groups (20.3% TCAR vs. 26.3% TFCAS; P = 0.08). In all carotid artery stenting cases, 30-day mortality was 2.4%, with 1.7% in-hospital deaths, 2% strokes, and 0.7% myocardial infarctions. Stroke/death occurred in 3.7%, MACE in 4.4%, access site complications in 4%, and technical failure was rare at 0.2%. TCAR was associated with lower 30-day mortality (1.2% vs. 2.9%), stroke (0.7% vs. 2.7%), MACE (2% vs. 5.5%), technical failure (0% vs. 0.3%), and access site complications (2% vs. 4.8%) than TFCAS. However, these differences were not statistically significant (P > 0.05). CONCLUSION: In this multi-institutional national study, both procedures showed acceptable stroke and death rates. Although not statistically significant, TCAR was associated with better technical success and periprocedural outcomes in CD management.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Abdelkarim A, Kricfalusi M, Arhuidese IJ, et al. Safety and Efficacy of Spontaneous Carotid Artery Dissection Management with Transfemoral Carotid Artery Stenting and Transcarotid Artery Revascularization: A Multi-Institutional Study. Ann Vasc Surg. 2025. PMID: 40436135. doi:10.1016/j.avsg.2025.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。